Tobias Mochel

发表

The discovery of CCR3/H1 dual antagonists with reduced hERG risk.

B. Springthorpe, P. Barton, R. Riley, 2012, Bioorganic & medicinal chemistry letters.

Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092.

Matthew W D Perry, Emma Roe, Robert J Riley, 2012, Bioorganic & medicinal chemistry letters.